Mammaglobin 1 mediates progression of trastuzumab‐resistant breast cancer cells through regulation of cyclins and NF‐κB

Overexpression of human epidermal growth factor receptor 2 (HER2) in various cancers is correlated with poor patient survival. Trastuzumab, a recombinant humanized monoclonal antibody against HER2, has been considered to be a first‐line therapy for HER2‐positive breast cancer patients, but its usefu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kusumastuti, Ratih, Kumagai, Yuji, Ishihara, Seiichiro, Enomoto, Atsushi, Murakami, Takashi, Yasuda, Motoaki, Haga, Hisashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527592/
https://www.ncbi.nlm.nih.gov/pubmed/35945910
http://dx.doi.org/10.1002/2211-5463.13468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527592/
https://www.ncbi.nlm.nih.gov/pubmed/35945910
http://dx.doi.org/10.1002/2211-5463.13468

Ejemplares similares